Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adverum Biotechnologies
Adverum Biotechnologies
(ADVM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ziv-aflibercept
choroidal neovascularization
,
macular edema
,
edema
,
diabetic retinopathy
,
macular degeneration
,
neoplasm metastasis
,
retinal neovascularization
,
pathologic neovascularization
Alpha1-proteinase inhibitor
alpha 1-antitrypsin deficiency
Aspartame
healthy volunteers/patients
,
laron syndrome
,
pituitary dwarfism
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
myeloid leukemia
,
erythroblastic leukemia acute
,
neoplasms
,
dyspnea
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
inflammation
Corticoids
neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use